This is the first study to demonstrate that the CDX2 expression status in CRCs was highly concordant between primary CRCs and their corresponding liver metastases, independent of chemotherapy, suggesting that the CDX2 expression status in CRC was not affected by metastasis or chemotherapy. This evidence concerns the gene CDX2 and colorectal carcinoma.